Comprehensive Patent Overview of Adenosine A2A Receptor Agonists - Discover Who is Citing your Patents Most Frequently.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c21485) has announced the addition of Patent Analysis of Adenosine adenosine /aden·o·sine/ (ah-den´o-sen) a purine nucleoside consisting of adenine and ribose; a component of RNA. It is also a cardiac depressant and vasodilator used as an antiarrhythmic and as an adjunct in myocardial perfusion imaging A2A A2A Access to Archives (UK) A2A Application to Application A2A Air-To-Air (weapon) A2A Administration-to-Administration A2A Any to Any Receptor Agonists to their offering. This is a competitive intelligence report of Adenosine A2A Agonists utilizing patent analysis. Extensive patent mining techniques were utilized to produce a base patent set of 202. This base set was then organized and analyzed for competitive intelligence. It has been reported that 75% of the information in patent documents is not available elsewhere. Therefore, this report provides valuable non-scientific literature data organized for actionable intelligence. The data from this report was collected through October 2004. The patent databases utilized were the USPTO USPTO abbr. United States Patent and Trademark Office (United States Patent and Trademark Office The United States Patent and Trademark Office (PTO or USPTO) is an agency in the United States Department of Commerce that provides patent protection to inventors and businesses for their inventions, and trademark registration for product and intellectual property ), EPO EPO see erythropoietin. EPO Erythropoietin, see there (European Patent Office), WIPO WIPO World Intellectual Property Organization WIPO World Intellectual Piracy Organization (satire website) WIPO Write in Poll Option WIPO Wing Information Protection Office (USAF) (World Intellectual Property Organization), DPMA (1) (Dynamic Power Management Architecture) Power management features built into Intel chipsets. By monitoring system activity and turning itself off when not required, DPMA chipsets use up to 75% less power than previous chipsets. (German Patent and Trade Mark Office) and the JPO JPO Joint Program Office JPO Japanese Patent Office JPO Journal of Prosthetics and Orthotics JPO Journal of Physical Oceanography JPO Juvenile Probation Officer JPO Jump If Parity Odd JPO Joint Pipeline Office JPO Joint Planning Office (Japan Patent Office). Highlights: --Comprehensive patent overview of Adenosine A2A receptor agonists --Backward and Forward Citation Maps --Innovation Speed and Patent Strength Indicators --Patent Distribution Charts of each company This report will give you an overview of major and minor players in the field. It enables you to assess your position in this area of research and discover potential acquisition targets. From reading this report you will learn the "Patent Strengths" of key patents. Discover who is citing your patents most frequently through cluster maps and who the key employees in a particular organization are with this analysis. Designed for: --Competitive Intelligence Analysts --Patent Information Professionals --Research Scientists --Patent Attorneys --Corporate Management --Merger & Acquisition Analysts Companies featured in the report - Actar AB - Adenosine Therapeutics - Boehringer Ingelheim Pharmaceuticals - Cadus Pharmaceutical - Cambridge Biotechnology Ltd. - Can-Fite Biopharma Ltd. - CV Therapeutics - Aderis Pharmaceuticals (Discovery Therapeutics) - Epigenesis Pharmaceuticals - Genaissance Pharmaceuticals - Glaxo Group Ltd. - Hoffmann-La Roche - Kyowa Hakko Kogyo Co Ltd. - Merckle GMBH - Nippon Shinyaku Ltd. - Novo Nordisk A/S - OSI Pharmaceuticals - Pfizer Inc. - Schering - Shionogi & Co Ltd. - SmithKline Beecham - TOA EIYO - Warner-Lambert Company - Whitby Research Inc. - Yamasa Shoyu For more information visit http://www.researchandmarkets.com/reports/c21485 |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion